| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Laboratory of Molecular Biology (X.-G.Z., S.-y.C.), Division of Basic Sciences, National Cancer Institute, and Laboratory of Biochemical Pharmacology (P.M.), National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, Maryland 20892-4255
Address all correspondence and requests for reprints to: Dr. Sheue-yann Cheng, Building 37, Room 2D24, 37 Convent Drive MSC 4255, Bethesda, Maryland 20892-4255. E-mail: sycheng{at}helix.nih.gov
General resistance to thyroid hormone is an inheritable disease with
resistance of peripheral tissues to elevated levels of thyroid hormone.
Genetic studies have shown that it is due to interference in the
functions of wild-type thyroid hormone nuclear receptors (wTRs) via the
dominant negative effect of mutant TRs (mTRs). The present study
compared the heterodimerization of the two TR isoforms, TRß1 and
TR
1, with mutant TRs to understand if mTRs had isoform-dependent
dominant negative action. Using electrophoresis gel mobility shift
assay, we have demonstrated that mutant PV, S, ED, and OK form
heterodimers with wTR
1 and
TRß1 (in which the A/B domain of
wTRß1 has been deleted), on the F2-thyroid hormone response element
(TRE). In the presence of T3, both homo- and heterodimer
complexes are dissociated in a T3 concentration dependent
manner. The ED50 for
TRß1 homodimers was 3-fold higher
than that of wTR
1 homodimers. ED50s for
TRß1/mTR
heterodimers were 10- to 40-fold higher than the corresponding
wTR
1/mTR heterodimers. Mutant ED and OK homodimers were only
partially dissociated at the highest T3 concentrations used
(100 nM), whereas no dissociation could be detected for PV
and S homodimers, indicating differential sensitivity of the F2-bound
TR dimers to the T3-induced dissociation. We presented a
model that indicates the dissociation of any particular TR dimer from
F2 is determined by competition of T3 for both of its
constituent TRs. By transfection assays, we showed that the potency of
the dominant negative action of PV on TR
1 and TRß1 inversely
correlated with the sensitivity of the appropriate mTR/wTR heterodimer
to T3-induced dissociation from F2. The differential
dominant negative action of mutants on the two TR isoforms could play
an important role in the heterogeneity of tissue-specific
manifestations in patients with resistance to thyroid hormone.
This article has been cited by other articles:
![]() |
A. M. Zavacki, H. Ying, M. A. Christoffolete, G. Aerts, E. So, J. W. Harney, S.-y. Cheng, P. R. Larsen, and A. C. Bianco Type 1 Iodothyronine Deiodinase Is a Sensitive Marker of Peripheral Thyroid Status in the Mouse Endocrinology, March 1, 2005; 146(3): 1568 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ying, H. Suzuki, L. Zhao, M. C. Willingham, P. Meltzer, and S.-Y. Cheng Mutant Thyroid Hormone Receptor {beta} Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor {gamma} during Thyroid Carcinogenesis Cancer Res., September 1, 2003; 63(17): 5274 - 5280. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suzuki, X.-Y. Zhang, D. Forrest, M. C. Willingham, and S.-Y. Cheng Marked Potentiation of the Dominant Negative Action of a Mutant Thyroid Hormone Receptor {beta} in Mice by the Ablation of One Wild-Type {beta} Allele Mol. Endocrinol., May 1, 2003; 17(5): 895 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Zhang, M. Kaneshige, Y. Kamiya, K. Kaneshige, P. McPhie, and S.-Y. Cheng Differential Expression of Thyroid Hormone Receptor Isoforms Dictates the Dominant Negative Activity of Mutant {beta} Receptor Mol. Endocrinol., September 1, 2002; 16(9): 2077 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-m. Lin, L. Zhao, and S.-y. Cheng Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors J. Biol. Chem., August 2, 2002; 277(32): 28733 - 28741. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |